Christy Chuang‐Stein

Author

Also Known As

C. Chuang-Stein, C. Chuang‐Stein, Christy Chuang-Stein, Christy Chuang-stein, Christy Chuang‐Stein, Chuang-Stein Christy, Chuang-Stein, Christy

166

Publications

3.4K

Citations

H-Index

150

Concepts

All Affiliations

Pfizer (United States)W.E. Upjohn Institute for Employment Research Eli Lilly (United States)Novartis (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Christy Chuang‐Stein is an author at Pfizer (United States) specializing in medicine, statistics, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	14	17	1.2K
2	Engineering	11	12	463
3	Business	1	1	26
4	Education	1	1	18
5	Law	1	1	10

Christy Chuang‐Stein

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR) Scott Evans, Daniel B. Rubin, Dean Follmann, Clinical Infectious Diseases Patient SelectionAntibiotic ResistanceDrug ResistancePreventive MedicineHealthcare-associated Infection	2015	323
Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group Paul Gallo, Christy Chuang‐Stein, Vladimir Dragalin, Journal of Biopharmaceutical Statistics White PaperOptimal Experimental DesignPharmacotherapyDrug DesignClinical Trials	2006	305
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia Earle Bain, Laura Shafner, David P. Walling, JMIR mhealth and uhealth	2017	160
Sample size and the probability of a successful trial Christy Chuang‐Stein Pharmaceutical Statistics ReliabilityEngineeringPatient RecruitmentTreatment EffectRandomized Controlled Trial	2006	125
Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America Walter Offen, Christy Chuang‐Stein, Alex Dmitrienko, Drug Information Journal MedicineClinical EndpointOutcomes ResearchPatient-reported OutcomeBiostatistics	2007	122
Statistics in the Pharmaceutical Industry. Christy Chuang‐Stein, C. Ralph Buncher, J. Y. Tsay Journal of the American Statistical Association Clinical EndpointTreatment EffectPharmacotherapyPharmaceutical PracticeAdaptive Design	1995	117
Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development Brenda Gaydos, Keaven M. Anderson, Donald A. Berry, Drug Information Journal Adaptive Clinical TrialsClinical Trial ManagementPharmacologyClinical TrialsRandomized Controlled Trial	2009	115
An Approach to Rationalize Partitioning Sample Size into Individual Regions in a Multiregional Trial Norisuke Kawai, Christy Chuang‐Stein, Osamu Komiyama, Drug Information Journal EngineeringMultiregional TrialSampling TechniquePartitioning Sample SizeComplex Sample	2008	86
Challenge of multiple co‐primary endpoints: a new approach Christy Chuang‐Stein, Paul Stryszak, Alex Dmitrienko, Statistics in Medicine Evidence-based TherapyMultiple Co‐primary EndpointsPsychopathologyMeta-analysisPsychiatry	2006	71
The relationship of blood transfusion, tumor staging, and cancer recurrence Neil Blumberg, Christy Chuang‐Stein, Joanna M. Heal Transfusion	1990	68

Page 1